BIOVAS

Baiwei (Wuhan) Medical Science and Technology Co., Ltd. is a technology enterprise dedicated to the production, research and development, and sales of medical devices, focusing on minimally invasive circulatory intervention-related products and targeting the global market. During the launch of its first-generation interventional products, the company entered the industrialization process for its core products, achieving the serialization, complementation, and scaling of its interventional product portfolio to provide comprehensive solutions. With a focus on peripheral vascular intervention and ENT (ear, nose, and throat) channel intervention, combined with product offerings in cardiac and respiratory interventions, the company maintains an overall leading position in China's interventional medical device sector.